A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)

NCT03675581 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Scleroderma, Systemic

Interventions

DRUG: Microgynon
DRUG: Nintedanib

Sponsor

Boehringer Ingelheim